Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Change in Receivables (2024 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Change in Receivables for 2 consecutive years, with -$131670.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 59.07% year-over-year to -$131670.0, compared with a TTM value of -$744107.0 through Oct 2025, down 243.49%, and an annual FY2025 reading of -$302068.0, down 165.54% over the prior year.
  • Change in Receivables was -$131670.0 for Q4 2025 at VitaNova Life Sciences, up from -$252669.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $460870.0 in Q2 2024 and bottomed at -$512980.0 in Q2 2025.